Background: Saddle pulmonary embolism represents a large clot and a risk for sudden hemodynamic collapse. However, the clinical presentation and outcomes vary widely. On the basis of the findings of right heart dysfunction on echocardiograms, computed tomography angiography, or cardiac enzyme elevation, some argue for the use of thrombolytics or catheter thrombectomy even for hemodynamically stable patients.
P ulmonary embolism (PE) is an important public health problem, accounting for many inhospital deaths, associated morbidity, and immense hospital costs (1) . The 3-month all-cause mortality rate for PE varies between 8.5% (2) and 18% (3) . The attributable mortality for PE is between 1.68% (2) and 7.9% (3) .
Saddle PE (SPE) is defined as the presence of a thromboembolus located at the bifurcation of the main pulmonary artery. Radiologic evidence of SPE is found in approximately 2% to 5% (4, 5) of all PE patients. However, the true frequency is difficult to determine since many patients are too unstable to receive a computed tomography angiography (CTA), and the diagnosis is often established at autopsy. Some have proposed that SPE represents a transient form of acute PE; thus, its true frequency may therefore be underestimated (6) . Saddle PE represents a large clot burden (CB) and is an important risk for right ventricular dysfunction and sudden hemodynamic collapse. Nonetheless, the clinical presentation and outcomes for these patients vary widely (7) . This is likely due to the variable compensatory physiologic responses and preexisting cardiorespiratory disease (8) . Some investigators argue for more aggressive therapeutic interventions (i.e., thrombolytics or catheter thrombectomy) in those patients with large CB even if hemodynamically stable. Such interventions are based on the findings of right heart dysfunction on echocardiograms (9) , CTA (10), or cardiac enzyme elevation (11) . These interventions may place this group of patients at an increased risk for medication-and procedure-related complications, lengthen the hospital stay, and increase hospitalization costs. The therapeutic value of these interventions in the setting of the normotensive patient with PE is still a matter of ongoing debate.
Few studies have documented the clinical presentation and outcomes of SPE on CTA. The purpose of this study was to retrospectively review our experience with patients diagnosed with SPE determined by CTA. We investigated the relationship between the radiologic find-ings and the clinical presentation, comorbidities, management strategies, and clinical outcomes. Our major goals were to determine the in-hospital mortality, the rates of adverse outcomes (i.e., major bleeding, minor bleeding), and in-hospital length of stay and to correlate them with the CB. The study was performed at the Albert Einstein Medical Center, a large tertiary teaching institution in Philadelphia, PA.
MATERIALS AND METHODS
Institutional Review Board approval was obtained with waiver of informed consent for this retrospective study. Patients with chest CTAs coded positive for PE (International Classification of Diseases, Ninth Revision, Clinical Modification codes 415.11-415.19) from June 1, 2004 , to February 28, 2009 , were identified using computer-assisted search of medical records. Patients younger than 18 yrs of age and those without a chest CTA were excluded.
Two radiologists reviewed all the computed tomography (CT) scans and selected only the patients with a radiologic finding of SPE, defined by a low-attenuation filling defect extending across the bifurcation of the pulmonary artery trunk. Both radiologists evaluated the CT scans for the presence or absence of inferior vena cava (IVC) contrast reflux and ventricular septal bowing, measured the ratio between the diameters of the right ventricle and the left ventricle (RV/LV), ratio between the diameters of the main pulmonary artery and the aorta, azygos vein di-ameter, and superior vena cave diameter, and scored the embolic burden and pulmonary artery occlusion. The CB and pulmonary artery occlusion index were determined using the Qanadli (12) scoring system. The maximal CB score was 40 (complete proximal obstruction of all 20 distal segmental arteries), corresponding to 100% occlusion ( Fig. 1 ). Both radiologists were blinded to the clinical history. We used three multidetector CT scanners: a GE Lightspeed 16-slice scanner and a GE Lightspeed VCT 64-slice scanner (GE Healthcare, Little Chalfont, U.K.) and a Toshiba Aquilion 16-slice scanner (Toshiba, Tokyo, Japan).
We extracted the clinical information, including demographics, clinical presentation, and echocardiographic and radiographic findings, as well as their treatments and outcomes. All patient identifiers were removed from the database. Echocardiographic data were extracted from the cardiology reports, and videotapes and were reviewed by one cardiologist. Only two-dimensional echocardiograms done within the first 72 hrs of presentation were included (Philips 5500 and Philips 7500 [Philips Healthcare, Andover, MA], GE vivid-I and GE vivid-7 [GE Healthcare], and Siemens Sequoia [Siemens Healthcare, Erlangen, Germany]). Multiple echocardiographic views are necessary to evaluate right ventricular size and function because the RV is a complex crescent-shaped structure wrapped around the LV and is incompletely viewed in any single two ϭ dimensional echocardiographic view (13) .
The parasternal long and short axis views, right ventricular inflow, and apical fourchamber and subcostal views were evaluated in all patients.
The right ventricular size was evaluated in all views but was best determined from the apical four-chambered view. In this view, the right ventricular midcavitary diameter is smaller than that of the LV. Mild right ventricular enlargement was defined as a mid right ventricular dimension equal to that of the LV diameter at that site. Moderate right ventricular enlargement was defined as a mid right ventricular dimension slightly larger than that of the LV but not displacing the left ventricular apex. Severe right ventricular enlargement was defined as a mid right ventricular dimension clearly exceeding the left ventricular dimension and the RV forming the apex of the heart (14) .
Right ventricular systolic function was subjectively evaluated in all views as is customary in clinical practice. Tricuspid annular plane systolic excursion (an index of right ventricular systolic function) was evaluated in the apical four-chambered view.
Tricuspid annular plane systolic excursion of Ͼ1.6 cm was considered normal. Mild right ventricular systolic dysfunction was defined as tricuspid annular plane excursion of Ͻ1.6 cm but Ͼ1.0 cm.
Moderate right ventricular dysfunction was defined as tricuspid annular plane excursions of Ͻ1.0 cm but Ͼ0.5 cm. Severe right ventricular dysfunction was defined as tricuspid annular plane excursion of Ͻ0.5 cm (15). The right ventricular systolic pressure was calculated by adding the estimated right atrial pressure (determined by the inferior vena cava diameter and its response to inspiratory decline with inspiration) to (tricuspid regurgitation velocity) 2 ϫ 4 (16) . The presence of the McConnell sign (akinesia of the mid free wall but normal motion of the apex) which is 77% sensitive and 94% specific for PE was determined (17) .
The highest serum troponin I in the initial 72 hrs was recorded. Electrocardiographic changes documented within the first 24 hrs of presentation were analyzed.
Most authors define shock as a systolic blood pressure of Ͻ90 mm Hg (17), while others have used a threshold of Ͻ100 mm Hg (8) . We elected to define it as a sustained or persistent systolic blood pressure of Յ90 mm Hg in more than one blood pressure measurement at presentation and, after Ն500 mL of intravenous crystalloid solutions, requirement of cardiopulmonary resuscitation or the use of vasoactive pressors. Those patients who responded to a fluid bolus were deemed to have transient hypotension. We defined major bleeding as a decrease in hemoglobin levels of 2 g/dL or more, blood product transfusion requirement, intracerebral bleeding, retroperitoneal bleeding, pericardial bleeding, bleeding that required a surgical intervention, bleeding into a major joint, or bleeding into the eye during the 48 hrs following thrombolytic administration. Any other bleeding that that did not fulfill these criteria was considered a minor bleed (18, 19) .
Measured variables were described using the median and interquartile range (IQR).
The Mann-Whitney U test was used to perform group comparisons of ordinal level (rank) variables. Percentages were compared using Fisher's exact test. Ninety-five percent confidence interval (95% CI) estimates were presented for percentages. All statistical analyses were performed using Stata 11 (Stata-Corp, College Station, TX).
RESULTS
Six hundred eighty patients were found to have a diagnosis of PE established by CTA. SPE was found in 37 of them (5.4%, 95% CI 4% to 7%).
The demographic characteristics and comorbidities of the 37 SPE patients are summarized in Table 1 . The median age was 60 yrs (IQR 21 yrs). Males comprised 40.5% of the SPE patients, and 84% were African-American. Thirty of 37 (81%) presented to the emergency department, and only seven (19%) developed SPE during a hospitalization.
The most frequent comorbidities were neurologic deficit (history of a cerebro-vascular accident) (9, 24%), surgical intervention within 3 months (9, 24%), and malignancy (8, 22%). There was a low prevalence of prior cardiopulmonary disease (4, 11%) and obesity (body mass index of Ͼ30) (4, 11%) ( Table 1) .
Dyspnea was the most common symptom (92%), followed by leg pain/edema (43%), chest pain (30%). and syncope (11%). One outpatient (3%) required mechanical ventilation. Persistent shock was seen in three patients (8%, 95% CI 2% to 22%). Transient hypotension was observed in six patients (16%, 95% CI 6% to 32%) but was rapidly corrected with fluid resuscitation. Upon the onset of symptoms, the median values of the vital signs were a systolic blood pressure of 112 mm Hg, diastolic blood pressure of 71 mm Hg, heart rate of 109 beats/min, respiration of 22 breaths/min, and pulse oximetry saturation of 94% on room air.
The median PaO 2 /FIO 2 ratio was 243 mm Hg (IQR 168 mm Hg) in the 19 patients in whom these data were available. The median brain natriuretic peptide was 251 (IQR 334). The median of the highest troponin I level was 0.08 ng/mL (IQR 0.17 ng/mL). The median Ddimer was 6772.5 (IQR 4039.5). Twentyeight patients had either CT venography or Doppler ultrasonography of the extremi-ties, identifying 20 patients (71%) with positive deep vein thrombosis ( Table 2) . Electrocardiographic abnormalities included sinus tachycardia (56%), right bundle branch block (22%), S 1 Q 3 T 3 pattern (25%), and new ST changes and nonspecific T wave inversions (64%). A normal electrocardiogram was observed in seven patients (19%).
Transthoracic echocardiography was performed in 27 patients (73%). RV enlargement was found in 21 patients (78%), and it was categorized as mild in six (22%), moderate in eight (30%), and severe in seven (26%) ( Table 2 ). RV dysfunction was seen in 21 patients (78%). It was mild in seven (26%), moderate in eight (30%), and severe in six (22%). Elevated pulmonary artery systolic pressure was seen in 18 (67%) patients. Interventricular septum flattening and/or left interventricular septum deviation was found in seven patients (26%). IVC failure to collapse on inspiration was observed in six patients (22%). Six patients had nor- CTA demonstrated a very high median pulmonary artery CB score of 31 points (IQR 6) of a maximum of 40 points (mean occlusion of 79%). The median pulmonary artery/aorta diameter ratio was 1.0 (IQR 0.21). The median RV/LV diameter ratio was 1.39 (IQR 0.91) (normal value Ͻ0.7). The median superior vena cava diameter was 23 mm (IQR 5 mm). The median azygos vein diameter was 11 mm (IQR 2 mm). Interventricular septum bowing was observed in 26 patients (70%) and contrast reflux in the IVC in 28 patients (76%) ( Table 2) .
Fifteen of 37 (41%) patients were treated in the intensive care unit, 17 (45%) in an intermediate care unit and telemetry, and five (14%) on the general medical floor (Table 3 ). Seventeen patients (46%) received IVC filters; the indications included presence of residual CB in the lower extremities (deep vein thrombosis) in five patients, contraindications to anticoagulation in eight patients, and a physician's preference in four patients. Of the 15 patients admitted to an intensive care unit with SPE, 11 (73.3%) received IVC filters compared to six of 22 (27.3%) patients admitted elsewhere in the hospital (p ϭ .008) by Fisher's exact test. In other words, those admitted to an intensive care unit were 2.7 times as likely to receive an IVC filter. The median length of stay for patients who received IVC filters (11 days) was longer than for those not receiving IVC filters (5.5 days) (p ϭ .002). The median length of stay for patients monitored in the intensive care unit was 11 days (IQR 5 days) and was 7 days (IQR 8 days) for patients monitored elsewhere in the hospital. However, no statistically significant difference was found (p ϭ .15).
Most patients (87%) received unfractionated heparin. Only four patients (11%) received intravenous thrombolytics (Alteplase, recombinant tissue plasminogen activator [r-TPA]; Genentech Inc, San Francisco, CA) ( Table 3) . Two of these patients received r-TPA due to concomitant shock. One survived hospitalization (length of stay 11 days) without bleeding or other complications. The other patient's course was complicated by pulseless electrical activity arrest, ventilator-dependent respiratory failure, gastrointestinal bleed, and sepsis, and this patient died with anoxic brain injury after 13 days in the hospital. One patient who was normotensive received r-TPA for a right ventricular thrombus seen on transthoracic echocardiography. This patient had severe RV dilation and dysfunction and CTA showing a CB of 37 (93% obstruction) with an RV/LV diameter ratio of 1.89. His course was complicated by a large arm hematoma, requiring blood transfusion and 11 days of hospitalization. A second normotensive patient received r-TPA after presenting with a history of syncope and severe abnormalities on CTA (CB of 33, or 83% obstruction, RV/LV diameter ratio 2.65) and transthoracic echocardiography (moderate RV dilation and dysfunction). His course was complicated by a minor bleed, and he was discharged after 11 days.
In those patients who did and did not receive thrombolytics, the median CB scores were 34 and 31, respectively. The median RV/LV ratio of those patients that did and did not receive thrombolytics was 1.86 and 1.34, respectively (p ϭ .13).
One patient with atrial dysrhythmia and recent right atrial radio frequency ablation, who developed shock, had a large tubular right atrial thrombus extending to the RV. He did not receive thrombolytics but was sent to a referral center for surgical thrombectomy.
In patients who received r-TPA, a major bleed was observed in two (50%) and a minor bleed in one (25%). One of 32 patients (3%) who received unfractionated heparin infusion developed a major bleed (gastrointestinal bleed).
The median length of stay in the hospital was 9 days (IQR 7 days). Only two of 37 patients with SPE (5.4%, 95% CI 1% to 18%) died in the hospital. One patient died after 13 days in the hospital with multiorgan failure, major bleeding, and sepsis. A second patient died in the emergency room with a bradycardic cardiopulmonary arrest due to an acute SPE. That patient had terminal lung cancer and was bedridden due to spinal and brain metastasis, and TPA was contraindicated. None of our patients received an autopsy.
The two patients who died had CBs of 30 and 31, respectively. Although almost half of the surviving patients had a higher CB than the two who died, the small number of deaths made it impossible to determine which characteristics were associated with mortality.
DISCUSSION
The cumulative frequency of SPE (5.4%) was similar to that of prior studies by Pruszczyk et al (4) (5.2%) and Ryu et al (5) (2.6%). However, this frequency of SPE may be an underestimate, since not all patients with SPE survive the initial event and many more delay medical care. In our study, only two of 37 patients (5.4%) died in the hospital.
This investigation contains one of the largest and best documented groups of patients with SPEs described in the literature. It incorporates a radiographic score of CB, echocardiographic features, and outcomes. Although ominous in appearance, an SPE may be a more common feature of many embolic events than previously thought when CTA is performed soon after symptoms begin.
Clinical and hemodynamic characteristics appear to be the most important predictors of adverse outcomes (2) . Systolic hypotension (Ͻ90 mm Hg) increased the risk of death substantially (odds ratio 18.6, 95% CI 11.2-31.1) (2). In the decision to utilize thrombolytic therapy, there is no consensus on any of the following: an absolute number for the systolic blood pressure, mean pressure, and duration of and response to fluid resuscitation in the definition of "systolic hypotension."
Six (16%) of the 37 patients had transient shock in the emergency room that corrected before the diagnosis and treatment of SPE. These patients did not receive thrombolytics. Persistent shock was seen in only three patients (8%, 95% CI 2% to 22%), two of whom received thrombolytics. Similar to our study, Ryu et al (5) found a frequency of hypotension of 14% (two patients), but only one patient received thrombolytics. Despite the high frequency of an abnormal finding on the electrocardiogram (81%) and on the echocardiogram (74%), the in-hospital mortality of SPE was low. RV enlargement and dysfunction were found very frequently (78%), as well as an elevated mean pulmonary artery systolic pressure (67%). Ryu et al (5) also found a high frequency of echocardiographic abnormalities in patients with SPE but had no in-hospital deaths. Pruszczyk et al (4) found no difference in the initial echocardiographic characteristics between patients with saddle and nonsaddle PE. These findings are not surprising as Miller et al (20) demonstrated discordance between the degree of perfusion abnormalities on ventilation/perfusion scans and RV enlargement or dysfunction. Similarly in hemodynamically stable patients with PE, Wolde et al (21) demonstrated a very poor positive predictive value (4% to 5%) of echocardiographic RV dysfunction predicting PErelated mortality. We feel that this discordance also applies to the CB score seen on CTA.
One concern is that RV dysfunction and dilation are relatively subjective determinations. Also, some studies that have concluded that the echocardiogram was useful in such patients may have had a selection bias (i.e., echocardiograms ordered mainly in sicker patients).
Only two in-hospital deaths occurred from SPE (5.4%) in our study, despite the presence of a high pulmonary artery CB (median 31 and 80% obstruction) and other ominous CTA signs, such as the RV/LV diameter ratio (mean 1.47), interventricular septum bowing (70%), and IVC reflux (76%). Neither of these two patients had underlying cardiopulmonary disease. Araoz et al (22) found that interventricular septum bowing in CTA was associated with a low sensitivity and high interobserver variability for predicting mortality in 30 days and that neither the RV/LV diameter ratio nor embolic burden was associated with death due to PE. This differs from two small CT studies (23, 24) where CB was associated with death due to PE over a 3-month period. The differing conclusions of these studies may have been a consequence of differing demographics or underlying cardiopulmonary comorbidities of those study groups.
An interesting observation was the more frequent use of IVC filters in those patients admitted to the intensive care unit. This could perhaps be explained by the number of patients who had residual CB in the lower extremity (found in nine of the 14 patients who received IVC filters). A contraindication to anticoagulation or physician preference also may have influenced the decision to insert a filter. The threshold to insert an IVC filter has been reduced since the introduction of retrievable filters. This may partially explain the increase in IVC use in patients with high CB (25) .
Pruszczyk et al (4) and Ryu et al (5) reported infrequent use of thrombolytics (29% and 7%, respectively). In our study, four patients (11%) received thrombolytics. The rate of major bleeding due to thrombolytics in our study was high compared to that in other studies (26) . Two of the four patients who received thrombolytics sustained major bleeding, and one had a minor bleed, prolonging their hospital stay. One major bleed occurred with unfractionated heparin, requiring its discontinuation and hence IVC filter placement. Even though there was a trend toward administration of thrombolytics with a higher CB score and RV/LV ratio, this did not reach statistical difference. A larger study is needed to investigate these associations.
The mean length of stay found in our SPE study (median 9) is slightly higher than the most recently reported length of stay for all PEs in the United States (8.6 days) (1). This likely reflects the safety concerns that many physicians have when discharging patients with SPE.
Only two (5.4%) patients with SPE died in the hospital. Pruszczyk et al (4) also observed low mortality (one of 17, 5.8%). In the study by Ryu et al (5) , none of the 14 patients died. The low prevalence of cardiopulmonary comorbidities in our patients as well as in these two studies may explain their relatively good outcomes. Patients with underlying cardiopulmonary disease would have excess risk of an adverse outcome with the amount of CB produced by an SPE (17, 27) . Wood (8) , however, reported no consistent relationship between the degree of cardiovascular and RV impairment and the magnitude of angiographic obstruction in those with underlying cardiopulmonary disease.
In one of our patients, death was directly attributed to an SPE event. The second death was related to complica-tions of a prolonged hospitalization, bleeding from thrombolytics, and multiple comorbidities appearing after a massive PE. In contrast, the only death from SPE in the study by Pruszczyk et al (4) was attributed to a recurrent PE, while Ryu et al (5) reported that all the patients with SPE who died 3 months after discharge died due to progression of an underlying malignancy.
